| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2004-05-1831 |
| P698 | PubMed publication ID | 15345590 |
| P50 | author | Catherine Klersy | Q43005750 |
| Vittorio Rosti | Q55069617 | ||
| Alessandro Pecci | Q56750104 | ||
| Margherita Massa | Q57316559 | ||
| Rita Campanelli | Q57597459 | ||
| Gaetano M. De Ferrari | Q61875250 | ||
| P2093 | author name string | Luigi Tavazzi | |
| Remigio Moratti | |||
| Roberta Rosso | |||
| Marco Ferlini | |||
| Maurizio Ferrario | |||
| Isabella Ramajoli | |||
| Alessandra Bertoletti | |||
| Lucio Goffredo | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| endothelium | Q111140 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 199-206 | |
| P577 | publication date | 2004-09-02 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction | |
| P478 | volume | 105 |
| Q37848705 | A comparison of stem cells for therapeutic use. |
| Q27690654 | A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkers |
| Q37291641 | A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction |
| Q38124918 | Activated platelets correlate with mobilization of naïve CD34+ cells and generation of CD34+/KDR+ cells in the circulation. A meta‐regression analysis |
| Q38057141 | Acute and chronic effects of exercise on circulating endothelial progenitor cells in healthy and diseased patients. |
| Q97073537 | Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers |
| Q35568131 | Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice |
| Q38103488 | Anti-Inflammatory Strategies for Plaque Stabilization after Acute Coronary Syndromes |
| Q37980252 | Are endothelial progenitor cells a prognostic factor in patients with heart failure? |
| Q53137736 | Arterial erectile dysfunction: Reliability of new markers of endothelial dysfunction |
| Q38467521 | Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients |
| Q34630397 | Association of colony-forming units with coronary artery and abdominal aortic calcification |
| Q37152177 | Atherosclerosis as a disease of failed endogenous repair |
| Q36242530 | Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome. |
| Q36853117 | Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction |
| Q36596218 | Biology of bone marrow-derived endothelial cell precursors |
| Q37783801 | Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy |
| Q36123176 | Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial |
| Q43215597 | Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results |
| Q37216693 | Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction |
| Q90019127 | CD34+ circulating cells display signs of immune activation in patients with acute coronary syndrome |
| Q47733538 | CD34-positive cells and their subpopulations characterized by flow cytometry analyses on the bone marrow of healthy allogenic donors |
| Q37967719 | CD34-positive stem cells: in the treatment of heart and vascular disease in human beings |
| Q43997305 | CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. |
| Q50988416 | Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury |
| Q43417603 | Cardiovascular event rates in patients with ST-elevation myocardial infarction were lower with early increases in mobilization of Oct4highNanoghigh stem cells into the peripheral circulation during a 4-year follow-up |
| Q58575098 | Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes |
| Q33552022 | Cholesterol and hematopoietic stem cells: inflammatory mediators of atherosclerosis |
| Q36829058 | Circulating Endothelial Cells and Endothelial Function Predict Major Adverse Cardiac Events and Early Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction |
| Q35935375 | Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis |
| Q34233678 | Circulating angiogenic factors in patients with thromboangiitis obliterans |
| Q33370283 | Circulating apoptotic progenitor cells in patients with congestive heart failure |
| Q37000599 | Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. |
| Q33416860 | Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study. |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q41109188 | Circulating endothelial progenitor cells are not affected by acute systemic inflammation |
| Q37269391 | Circulating endothelial progenitor cells in cardiovascular disorders |
| Q35954256 | Circulating endothelial progenitor cells in patients with cardiac syndrome X. |
| Q33582866 | Circulating endothelial progenitor cells: a new approach to anti-aging medicine? |
| Q34619426 | Circulating very small embryonic-like stem cells in cardiovascular disease |
| Q95633714 | Clinical approach to the inflammatory etiology of cardiovascular diseases |
| Q37661456 | Clinical implication of endothelial progenitor cells |
| Q34389649 | Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome |
| Q37471414 | Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. |
| Q26862738 | Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis |
| Q36055443 | Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. |
| Q53215340 | Darbepoetin enhances endothelium-dependent vasomotor function in patients with stable coronary artery disease only after preceding ischaemia/reperfusion |
| Q33783495 | Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. |
| Q80738488 | Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction |
| Q57032115 | Distinct Dynamics of Stem and Progenitor Cells in Blood of Polytraumatized Patients |
| Q36861611 | Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction |
| Q34658637 | E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4. |
| Q33558915 | EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy |
| Q35903365 | Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study |
| Q35566925 | Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. |
| Q34074673 | Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial |
| Q36844897 | Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients |
| Q35959064 | Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction |
| Q82662237 | Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans |
| Q42510972 | Effects of haemodialysis on circulating endothelial progenitor cell count. |
| Q53186699 | Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells |
| Q41965362 | Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease. |
| Q26770056 | Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease |
| Q47141294 | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application |
| Q44299935 | Endothelial Progenitor Cells in Acute Myocardial Infarction and Sleep-disordered Breathing |
| Q90475042 | Endothelial Progenitor Cells in Moyamoya Disease: Current Situation and Controversial Issues |
| Q59806239 | Endothelial colony-forming cell therapy for heart morphological changes after neonatal high oxygen exposure in rats, a model of complications of prematurity |
| Q37863567 | Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea |
| Q37815308 | Endothelial progenitor cells as therapeutic agents in the microcirculation: an update |
| Q35765879 | Endothelial progenitor cells enter the aging arena |
| Q50035033 | Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models |
| Q37894942 | Endothelial progenitor cells in cardiovascular disease and hypoxia--potential implications to obstructive sleep apnea |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q39471236 | Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease |
| Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
| Q36603898 | Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases |
| Q40311493 | Endothelial progenitor cells: from bench to bedside |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q38951940 | Evaluation of late outgrowth endothelial progenitor cell and umbilical vein endothelial cell responses to thromboresistant collagen-mimetic hydrogels. |
| Q36499216 | Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury |
| Q34355986 | Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia. |
| Q59116753 | Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia |
| Q37418551 | From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. |
| Q58863641 | Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease |
| Q80735257 | Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes |
| Q35919702 | Genetic and clinical correlates of early-outgrowth colony-forming units |
| Q37538723 | Genous endothelial progenitor cell-capturing stent system: a novel stent technology |
| Q56008653 | Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia |
| Q38552119 | Growth factors enhance liver regeneration in acute-on-chronic liver failure |
| Q34333348 | Human endothelial stem/progenitor cells, angiogenic factors and vascular repair |
| Q41290236 | Hyperbaric environment up-regulates CD15s expression on leukocytes, down-regulates CD77 expression on renal cells and up-regulates CD34 expression on pulmonary and cardiac cells in rat. |
| Q37383093 | Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial |
| Q30316648 | Imaging systemic inflammatory networks in ischemic heart disease |
| Q36353200 | Immortalized functional endothelial progenitor cell lines from umbilical cord blood for vascular tissue engineering. |
| Q53509755 | Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes |
| Q38253911 | Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart |
| Q26771257 | Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis |
| Q51753960 | Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease |
| Q63435769 | Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study |
| Q35855818 | In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. |
| Q34586902 | In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome |
| Q37112681 | Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study |
| Q44338902 | Increased circulating CD3+/CD31+ T cells in patients with acute coronary syndrome |
| Q33953737 | Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. |
| Q100514535 | Increased circulating endothelial progenitor cells (EPCs) in prepubertal children born prematurely: a possible link between prematurity and cardiovascular risk |
| Q51673633 | Increased haematopoietic activity in patients with atherosclerosis |
| Q38355385 | Inflammatory markers in ST-elevation acute myocardial infarction |
| Q47694655 | Inhalation of Fine Particulate Matter Impairs Endothelial Progenitor Cell Function Via Pulmonary Oxidative Stress |
| Q36681493 | Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction? |
| Q90729475 | Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects |
| Q27025843 | Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction? |
| Q57805880 | Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview |
| Q38187672 | Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases. |
| Q47721996 | Is cell therapy in acute lung injury a realistic dream? |
| Q31133829 | LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis |
| Q34322056 | Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure |
| Q38667788 | Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling |
| Q42874906 | Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies |
| Q36979376 | Level of CD14+-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors |
| Q33694895 | Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction. |
| Q34142382 | Loss of Sirt3 limits bone marrow cell-mediated angiogenesis and cardiac repair in post-myocardial infarction |
| Q46350318 | Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men. |
| Q36198168 | Lysophospholipids in coronary artery and chronic ischemic heart disease |
| Q63915886 | Macrophages and Cardiovascular Health |
| Q35289180 | Macrophages retain hematopoietic stem cells in the spleen via VCAM-1 |
| Q35040521 | Maternal high-fat diet and obesity compromise fetal hematopoiesis |
| Q27308049 | Matrix production and organization by endothelial colony forming cells in mechanically strained engineered tissue constructs |
| Q42439863 | Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction |
| Q35876556 | Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remodeling in 1-year follow-up of patients with acute myocardial infarction |
| Q64084427 | Mobilization of Stem and Progenitor Cells in Septic Shock Patients |
| Q41189527 | Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction |
| Q61771939 | Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and stroke |
| Q34565160 | Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen |
| Q37905521 | Mobilization of stem and progenitor cells in cardiovascular diseases |
| Q37803545 | Mobilization of very small embryonic-like stem cells in acute coronary syndromes and stroke |
| Q37122225 | Monocyte and macrophage heterogeneity in the heart |
| Q36106602 | Myocardial infarction accelerates atherosclerosis. |
| Q34988169 | Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction |
| Q38183938 | Next-generation DES: the COMBO dual therapy stent with Genous endothelial progenitor capturing technology and an abluminal sirolimus matrix |
| Q48021276 | Nocturnal stem cell mobilization in patients with obstructive sleep apnoea: a pilot study. |
| Q42942990 | Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment |
| Q39461796 | Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprinted L3MBTL1 gene. |
| Q36969719 | Plasmin therapy enhances mobilization of HPCs after G-CSF |
| Q38384991 | PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. |
| Q47356303 | Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction |
| Q93062171 | Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid |
| Q35753126 | Production of Human Endothelial Cells Free from Soluble Xenogeneic Antigens for Bioartificial Small Diameter Vascular Graft Endothelization. |
| Q87993873 | Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q37053167 | Progenitor cells and vascular disease |
| Q38522829 | Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation |
| Q88574584 | Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q37444118 | Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction |
| Q84794301 | Recruitment by SDF-1α of CD34-positive cells involved in sciatic nerve regeneration |
| Q33847880 | Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. |
| Q37283470 | Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources |
| Q38174769 | Regenerative therapy for cardiovascular disease |
| Q30341692 | Regulation of glycosaminoglycan structure and atherogenesis. |
| Q84105610 | Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques |
| Q43292766 | Relationship between stem cell factor/c-kit expression in peripheral blood and blood pressure |
| Q53357001 | Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm |
| Q37126579 | Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control |
| Q26766306 | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis |
| Q54573577 | Spleen deflation and beyond: the pros and cons of Janus kinase 2 inhibitor therapy for patients with myeloproliferative neoplasms. |
| Q86695109 | Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q36368239 | Stem cell transplantation for the treatment of myocardial infarction |
| Q35128063 | Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation |
| Q37665063 | Stem cell-mediated neovascularization in heart repair |
| Q55052506 | TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. |
| Q37520596 | Targeting angiogenesis to restore the microcirculation after reperfused MI. |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q35148886 | The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study |
| Q36517255 | The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD |
| Q37594948 | The role of bioactive lipids in stem cell mobilization and homing: novel therapeutics for myocardial ischemia |
| Q54542007 | The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia. |
| Q47763374 | Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease. |
| Q40348049 | Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction |
| Q50849491 | Towards a biofunctionalized vascular prosthesis: immune cell trapping via a growth factor receptor |
| Q39001566 | Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs |
| Q84642752 | Umbilical Cord Blood Stem Cells for Myocardial Repair and Regeneration |
| Q36763252 | Umbilical cord blood stem cells: implications for cardiovascular regenerative medicine |
| Q37194131 | Understanding the application of stem cell therapy in cardiovascular diseases |
| Q43464268 | Update in sleep medicine 2013. |
| Q39174289 | Vascular precursor cells in tissue injury repair |
| Q34914352 | Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: Increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy |
| Q34419924 | Very small embryonic-like stem cells in cardiovascular repair |
| Q37824871 | Very small embryonic-like stem cells: biology and therapeutic potential for heart repair |
| Q28295515 | Working hypothesis to redefine endothelial progenitor cells |
Search more.